Cipla Collaborates with Kemwell to Form Joint Venture to Develop and Commercialize Biosimilars
Shots:
- The companies collaborated to form JV to develop- manufacture- and commercialize biosimilars for a global market
- The collaboration will utilize Cipla and Kemwell’s strengths for product development- clinical development- regulatory filings- manufacturing- and commercialization of biopharma products
- Cipla’s respiratory expertise & Kemwell’s biologics will combine to accelerate the products in the market
Ref: Biogen | Image: Stat News
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com